Literature DB >> 16091784

Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip Goldblatt hypertension mouse model.

Neetu Tyagi1, Karni S Moshal, David Lominadze, Alexander V Ovechkin, Suresh C Tyagi.   

Abstract

Accumulation of interstitial collagen (fibrosis) between the endothelium and myocytes is one of the hallmarks of cardiac failure in renovascular hypertension (RVH). Renal insufficiency increases plasma homocysteine (Hcy), and levels of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) are inversely related to plasma Hcy levels. We hypothesize that in RVH, accumulation of collagen between the endothelium and myocytes leads to endothelial-myocyte disconnection and uncoupling, in part, by hyperhomocysteinemia. Furthermore, we hypothesize that Hcy increases reactive oxygen species, generates nitrotyrosine, activates latent matrix metalloproteinase, and decreases the levels of endothelial nitric oxide in response to antagonizing PPAR-gamma. To create RVH in mice, the left renal artery was clipped with 0.4-mm silver wire for the 2 kidney, 1 clip (2K1C) method. Sham surgery was used as a control. To induce PPAR-gamma, 8 microg/mL ciglitazone (CZ) was administered to drinking water 2 days before surgery and continued for 4 weeks. Mice were grouped as 2K1C, sham, 2K1C+CZ, or sham+CZ (n = 6 in each group). Plasma Hcy increased 2-fold in the 2K1C-treated group (p < 0.05) as compared with the sham, and CZ had no effect on Hcy levels as compared to the 2K1C-treated group. Hcy binding in cardiac tissue homogenates decreased in the 2K1C-treated group but was substantially higher in the CZ-treated group. Cardiac reactive oxygen species levels were increased and endothelial nitric oxide were decreased in the 2K1C-treated group. Matrix metalloproteinase-2 and -9 activities were increased in the 2K1C-treated group compared with the control. Levels of cardiac inhibitor of metalloproteinase were decreased, whereas there was no change in tissue inhibitor of metalloproteinase-1 expression in the 2K1C-treated group vs. the sham-treated group. Collagen and nitrotyrosine levels were increased in the 2K1C-treated group, but mice treated with CZ showed lower levels comparatively. Cardiac transferase deoxyuridine nick-end labeling-positive cells were increased, and muscle cells were impaired in the 2K1C-treated mice vs. the sham-control mice. This was associated with decreased acetylcholine and bradykinin responses, which suggests endothelial-myocyte uncoupling in 2K1C-treated mice. Our results suggest that fibrosis between the endothelium and myocytes leads to an endothelial-myocyte disconnection and uncoupling by Hcy accumulation secondary to increased reactive oxygen species, nitrotyrosine, matrix metalloproteinase, and decreased endothelial nitric oxide in response to antagonizing PPAR-gamma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091784     DOI: 10.1139/y05-047

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  7 in total

1.  Mesenteric vascular remodeling in hyperhomocysteinemia.

Authors:  C Munjal; S Givvimani; N Qipshidze; N Tyagi; J C Falcone; S C Tyagi
Journal:  Mol Cell Biochem       Date:  2010-11-13       Impact factor: 3.396

2.  Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia.

Authors:  Neetu Tyagi; Natia Qipshidze; Utpal Sen; Walter Rodriguez; Alexander Ovechkin; Suresh C Tyagi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-09-08

3.  C677T MTHFR Gene Polymorphism is Contributing Factor in Development of Renal Impairment in Young Hypertensive Patients.

Authors:  Hanaa H Elsaid; Khaled A El-Hefnawy; Saffaa M Elalawi
Journal:  Indian J Clin Biochem       Date:  2020-05-14

4.  Homocysteine as a risk factor for hypertension: a 2-year follow-up study.

Authors:  Yixuan Wang; Shuohua Chen; Tao Yao; DongQing Li; YanXiu Wang; YuQing Li; ShouLing Wu; Jun Cai
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

5.  Modification of Platelet Count on the Association between Homocysteine and Blood Pressure: A Moderation Analysis in Chinese Hypertensive Patients.

Authors:  Jianan Zhang; Jing Li; Shi Chen; Linglin Gao; Xiaoluan Yan; Mingzhi Zhang; Jia Yu; Fenchun Wang; Hao Peng
Journal:  Int J Hypertens       Date:  2020-02-14       Impact factor: 2.420

6.  Vascular Remodeling, Oxidative Stress, and Disrupted PPARγ Expression in Rats of Long-Term Hyperhomocysteinemia with Metabolic Disturbance.

Authors:  Yajing Huo; Xuqing Wu; Jing Ding; Yang Geng; Weiwei Qiao; Anyan Ge; Cen Guo; Jianing Lv; Haifeng Bao; Wei Fan
Journal:  PPAR Res       Date:  2018-01-15       Impact factor: 4.964

7.  Association between plasma levels of homocysteine, folate, and vitamin B12, and dietary folate intake and hypertension in a cross-sectional study.

Authors:  Takashi Tamura; Nagato Kuriyama; Teruhide Koyama; Etsuko Ozaki; Daisuke Matsui; Yuka Kadomatsu; Mineko Tsukamoto; Yoko Kubo; Rieko Okada; Asahi Hishida; Tae Sasakabe; Sayo Kawai; Mariko Naito; Naoyuki Takashima; Aya Kadota; Keitaro Tanaka; Megumi Hara; Sadao Suzuki; Hiroko Nakagawa-Senda; Toshiro Takezaki; Ippei Shimoshikiryo; Hiroaki Ikezaki; Masayuki Murata; Isao Oze; Hidemi Ito; Haruo Mikami; Yohko Nakamura; Kiyonori Kuriki; Kokichi Arisawa; Hirokazu Uemura; Kenji Takeuchi; Kenji Wakai
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.